๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of rhodamine 123 in the treatment of the pollard iii rat prostate adenocarcinoma

โœ Scribed by John A. Arcadi

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
622 KB
Volume
44
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

โœฆ Synopsis

Significant destruction of the Pollard 111 rat prostate adenocarcinoma was achieved by treatment with rhodamine 123 at a dosage of 15 mg/kg every other day for 33 to 38 days. Injection of tumor remnants into untreated animals produced no tumor regrowth. Our data have demonstrated rhodamine 123 to bc a significant drug for the management of the very aggressive Pollard 111 tumor.

๐Ÿ“œ SIMILAR VOLUMES

Adriamycin-vitamin E combination therapy
Adriamycin-vitamin E combination therapy for treatment of prostate adenocarcinoma in the NB rat model
โœ John A. Nesbitt; Jeffery Smith; Gladstone McDowell; Joseph R. Drago ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 179 KB

Adriamycin used in combination with vitamin E (Tocopherol) was evaluated in the treatment of Nb rat prostate adenocarcinoma. Vitamin E has been shown to enhance the growth-inhibitory effects of adriamycin on human prostatic carcinoma cells in vitro. The adriamycin-vitamin E treatment groups had the

Bicalutamide dosages used in the treatme
Bicalutamide dosages used in the treatment of prostate cancer
โœ Kolvenbag, Geert J.C.M.; Nash, Anthony ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 200 KB ๐Ÿ‘ 2 views

## BACKGROUND. Androgen deprivation is often used for the treatment of patients with prostate cancer. Androgen deprivation can be achieved by surgical castration or medical castration, with or without using an antiandrogen. Each of these treatments may be used alone, or an antiandrogen may be used